Debiopharm Innovation Fund

Debiopharm Innovation Fund offers a strategic investments in for companies and businesses.

Business Model:

Revenue: $43.3M

Employees: 201-500

Rankings

Detailed Debiopharm Innovation Fund Information

Geographic Data

Debiopharm Innovation Fund headquarters map

Address: Chemin Messidor 5-7

City: Lausanne

State: vaud

Zip: CH-1002

Country: CH

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$0

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Debiopharm Innovation Fund invests in digital health companies that have an impact on cancer, infectious diseases, and drug development. We are looking for ambitious entrepreneurs raising series A or B with clinically proven, transformative technologies that use AI and data to help patients. We do not invest in consumer wellness or workflow solutions. Our initial investment is typically $2-5M. Along with capital we bring deep pharma knowledge &a; networks and long-term commitment to help build value in your company. We are an evergreen investment fund of the pharmaceutical company Debiopharm based in Lausanne, Switzerland.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
7/2020 Nucleai Series A 0
2/2021 Carevive Systems Series C 0
3/2022 VivoSense Series A 0
5/2017 BC Platforms Series B 10M
11/2013 Biocartis Series E 0
9/2020 Oncomfort Series A 0
11/2014 Coorpacademy Series A 4M
3/2023 Genialis Series A 0
5/2022 Mika Series A 0
2/2020 Carevive Systems Series C 0
11/2020 Voluntis Post-IPO Equity -
12/2019 BC Platforms Series C 15M
4/2018 Kaiku Health Series A 5.4M
11/2021 Mekonos Series A 0
6/2005 Neovacs Venture Round -
10/2012 Searchbox Series B -
3/2022 Nucleai Series B 0
1/2022 VeriSIM Life Series A 0
2/2018 ABAC Therapeutics Series A 0
11/2022 YonaLink Seed Round 6M
6/2013 Diagnoplex Venture Round 1.4M
9/2013 KeyLemon Series A 1.5M
5/2022 Mika Series A 0
3/2022 VivoSense Series A 0
3/2022 Nucleai Series B 0
1/2022 VeriSIM Life Series A 0
11/2021 Mekonos Series A 0
2/2021 Carevive Systems Series C 0
11/2020 Voluntis Post-IPO Equity -
9/2020 Oncomfort Series A 0
7/2020 Nucleai Series A 0
2/2020 Carevive Systems Series C 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research